Therefore, the background for the initiation of this study was to select only MPA patients with positive MPO-ANCA and determine whether the therapeutic and preventive effect of RTX on progression to ESKD would be better in patients with higher MPO-ANCA titre or with lower MPO-ANCA titre measured at diagnosis. This evidence concerns the gene MPO and microscopic polyangiitis.